Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Aylar Imanpour"'
Autor:
Aylar Imanpour, Hanieh Kolahi Azar, Dorna Makarem, Zeinab Nematollahi, Reza Nahavandi, Mohammadreza Rostami, Nima Beheshtizadeh
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-22 (2023)
Abstract Osteoporosis is a bone condition characterized by reduced bone mineral density (BMD), poor bone microarchitecture/mineralization, and/or diminished bone strength. This asymptomatic disorder typically goes untreated until it presents as a low
Externí odkaz:
https://doaj.org/article/119c18ab895644e48815110cc3e5ab5c
Autor:
Aylar Imanpour, Hanieh Kolahi Azar, Dorna Makarem, Zeinab Nematollahi, Reza Nahavandi, Mohammadreza Rostami, Nima Beheshtizadeh
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-1 (2024)
Externí odkaz:
https://doaj.org/article/72e472f741344a52bf27c2eaef5b9346
Autor:
Hanieh Kolahi Azar, Aylar Imanpour, Hanieh Rezaee, Fatemeh Ezzatifar, Zeinab Zarei‐Behjani, Mohammadreza Rostami, Mahmoud Azami, Nima Behestizadeh, Nima Rezaei
Publikováno v:
European Journal of Haematology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3baf1f45ce5322a6df68f90e454bb02e
https://doi.org/10.1111/ejh.14014
https://doi.org/10.1111/ejh.14014
Autor:
Sima Rezvantalab, Aylar Imanpour
At present, the FDA approved some drugs for treating migraines such as Ubrogepant and Rimegepant by targeting the calcitonin-gene-related peptide receptor (CGRPR). Although nanomaterials have been recognized as useful as drug carriers or therapeutics
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dc4949b400be1d0e09d7d7a81c1f02f8
https://doi.org/10.21203/rs.3.rs-2169537/v1
https://doi.org/10.21203/rs.3.rs-2169537/v1
Publikováno v:
SSRN Electronic Journal.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bb4ffdb44b98680527186ffaaa629d20
https://doi.org/10.2139/ssrn.3907898
https://doi.org/10.2139/ssrn.3907898
Publikováno v:
Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1870:140769
Proteolytically cleavage of the collagen NC1 α1 to α3 (IV) domains leads to antiangiogenic proteins called Arresten, Canstatin, and Tumstatin, respectively. The research identified that the two overlapping peptides derived from Tumstatin are more e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb1dcf48cab33844636caab0db0a78be
https://doi.org/10.1016/j.bbapap.2022.140769
https://doi.org/10.1016/j.bbapap.2022.140769